Cargando…

Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer

Among the 518 protein kinases encoded by the human kinome, several of them act as oncoproteins in human cancers. Like other eukaryotic genes, oncogenes encoding protein kinases are frequently subjected to alternative splicing in coding as well as noncoding sequences. In the present paper, we will il...

Descripción completa

Detalles Bibliográficos
Autores principales:	Druillennec, Sabine, Dorard, Coralie, Eychène, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189609/ https://www.ncbi.nlm.nih.gov/pubmed/22007291 http://dx.doi.org/10.1155/2012/639062

Ejemplares similares

B-raf Alternative Splicing Is Dispensable for Development but Required for Learning and Memory Associated with the Hippocampus in the Adult Mouse
por: Valluet, Agathe, et al.
Publicado: (2010)

RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma
por: Dorard, Coralie, et al.
Publicado: (2017)

NRAS-driven melanoma: A RAF can hide another
por: Druillennec, Sabine, et al.
Publicado: (2017)

Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity
por: Duvillié, Bertrand, et al.
Publicado: (2020)

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy
por: Bonomi, Serena, et al.
Publicado: (2013)

Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer
por: Lo, April, et al.
Publicado: (2022)

How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
por: Wojtyś, Weronika, et al.
Publicado: (2023)

Splicing is an alternate oncogenic pathway activation mechanism in glioma
por: Siddaway, Robert, et al.
Publicado: (2022)

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells
por: Estrada, Charlène, et al.
Publicado: (2022)

From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
por: Tian, Na, et al.
Publicado: (2017)

Tuning of Alternative Splicing - Switch From Proto-Oncogene to Tumor Suppressor
por: Shchelkunova, Aleksandra, et al.
Publicado: (2012)

Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology
por: Imbriano, Carol, et al.
Publicado: (2018)

Alternative Splicing by NOVA Factors: From Gene Expression to Cell Physiology and Pathology
por: Meldolesi, Jacopo
Publicado: (2020)

Alternative Splicing in Human Physiology and Disease
por: Artemaki, Pinelopi I., et al.
Publicado: (2022)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010)

Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019)

Small Molecule Amiloride Modulates Oncogenic RNA Alternative Splicing to Devitalize Human Cancer Cells
por: Chang, Jan-Gowth, et al.
Publicado: (2011)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)

Alternative Splicing in Cancer and Immune Cells
por: Bernard, Antoine, et al.
Publicado: (2022)

Genetic variations and alternative splicing: the Glioma associated oncogene 1, GLI1
por: Zaphiropoulos, Peter G.
Publicado: (2012)

Oncogenes and RNA splicing of human tumor viruses
por: Ajiro, Masahiko, et al.
Publicado: (2014)

Alternative Splicing Programs in Prostate Cancer
por: Sette, Claudio
Publicado: (2013)

Significance of alternative splicing in cancer cells
por: Qi, Fei, et al.
Publicado: (2020)

The Function and Regulation of SAPCD2 in Physiological and Oncogenic Processes
por: Baker, Amy L., et al.
Publicado: (2022)

Alternative splicing in cardiomyopathy
por: Beqqali, A.
Publicado: (2018)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Alternative splicing and protein function
por: Neverov, AD, et al.
Publicado: (2005)

Role of RNA Alternative Splicing in T Cell Function and Disease
por: Banerjee, Shefali, et al.
Publicado: (2023)

Alternative splicing and the progesterone receptor in breast cancer
por: Cork, David MW, et al.
Publicado: (2008)

Alternative Splicing as a Target for Cancer Treatment
por: Martinez-Montiel, Nancy, et al.
Publicado: (2018)

Noncoding RNAs regulate alternative splicing in Cancer
por: Liu, Yunze, et al.
Publicado: (2021)

Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
por: Zheng, Xiang, et al.
Publicado: (2020)

Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression
por: Ni, Beibei, et al.
Publicado: (2016)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Alternative Splicing and Isoforms: From Mechanisms to Diseases
por: Liu, Qi, et al.
Publicado: (2022)

Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer
por: Naro, Chiara, et al.
Publicado: (2013)

Alternative Splicing for Diseases, Cancers, Drugs, and Databases
por: Tang, Jen-Yang, et al.
Publicado: (2013)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ncjpi27fbdge1m04npp2800hqt